Chennai Meenakshi Multispeciality Hospital Limited (BOM:523489)
India · Delayed Price · Currency is INR 36.61
+0.01 (0.03%)
At close: Oct 1, 2026
BOM:523489 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 273 | 247 | 230 | 252 | 139 | 173 | |
Market Cap Growth | -16.03% | 7.00% | -8.54% | 81.83% | -19.87% | 137.68% |
Enterprise Value | 327 | 306 | 299 | 315 | 210 | 243 |
Last Close Price | 36.61 | 33.01 | 30.85 | 33.73 | 18.55 | 23.15 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | 15.56 | 4.35 |
PS Ratio | 0.74 | 0.67 | 0.66 | 0.66 | 0.36 | 0.55 |
PB Ratio | -8.89 | -8.02 | -12.21 | -76.92 | 113.94 | -22.26 |
P/TBV Ratio | - | - | - | - | 113.94 | - |
P/FCF Ratio | 102.26 | 92.20 | 12.12 | - | 7.45 | 11.09 |
P/OCF Ratio | 74.61 | 67.27 | 10.60 | 12.06 | 4.70 | 4.36 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.89 | 0.83 | 0.86 | 0.82 | 0.54 | 0.77 |
EV/EBITDA Ratio | 54.36 | 1490.36 | - | 16.60 | 6.94 | 4.23 |
EV/EBIT Ratio | - | - | - | 42.59 | 11.37 | 5.31 |
EV/FCF Ratio | 122.39 | 114.26 | 15.75 | - | 11.31 | 15.57 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | -3.45 | -3.45 | -5.63 | -34.86 | 87.39 | -13.68 |
Debt / EBITDA Ratio | 17.65 | 518.36 | - | 6.02 | 3.51 | 1.85 |
Debt / FCF Ratio | - | 39.74 | 5.59 | - | 5.71 | 6.81 |
Net Debt / Equity Ratio | -1.75 | -1.75 | -3.83 | -23.30 | 50.16 | -9.51 |
Net Debt / EBITDA Ratio | 8.94 | 262.63 | -35.53 | 4.03 | 2.01 | 1.29 |
Net Debt / FCF Ratio | - | 20.14 | 3.80 | -65.21 | 3.28 | 4.74 |
Asset Turnover | - | 1.69 | 1.54 | 1.70 | 1.78 | 1.55 |
Inventory Turnover | - | 42.30 | 40.60 | 43.58 | 42.60 | 35.17 |
Quick Ratio | - | 0.52 | 0.35 | 0.44 | 0.57 | 0.41 |
Current Ratio | - | 0.67 | 0.53 | 0.65 | 0.76 | 0.66 |
Return on Assets (ROA) | - | -3.06% | -3.77% | 2.06% | 5.32% | 14.08% |
Return on Invested Capital (ROIC) | - | -11.08% | -12.19% | -33.15% | 15.26% | 50.68% |
Return on Capital Employed (ROCE) | - | -11.90% | -13.30% | 6.10% | 15.80% | 42.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -1.37% | -4.53% | -5.96% | -1.70% | 6.43% | 22.99% |
FCF Yield | 0.98% | 1.08% | 8.25% | -0.46% | 13.43% | 9.02% |
Buyback Yield / Dilution | - | - | - | - | 0.00% | -0.00% |